Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Failure, Acute | 5 | 2020 | 10 | 1.430 |
Why?
|
| Acetaminophen | 4 | 2020 | 20 | 1.310 |
Why?
|
| Neurology | 1 | 2024 | 50 | 0.810 |
Why?
|
| Registries | 4 | 2019 | 328 | 0.440 |
Why?
|
| Rare Diseases | 1 | 2014 | 21 | 0.440 |
Why?
|
| Models, Theoretical | 1 | 2015 | 146 | 0.410 |
Why?
|
| Models, Statistical | 1 | 2014 | 193 | 0.400 |
Why?
|
| Algorithms | 1 | 2014 | 561 | 0.340 |
Why?
|
| Biostatistics | 2 | 2024 | 8 | 0.330 |
Why?
|
| Area Under Curve | 3 | 2019 | 98 | 0.290 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2020 | 8 | 0.290 |
Why?
|
| ROC Curve | 3 | 2019 | 176 | 0.280 |
Why?
|
| Biomedical Research | 2 | 2024 | 186 | 0.240 |
Why?
|
| Databases, Factual | 2 | 2019 | 380 | 0.230 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 922 | 0.230 |
Why?
|
| Research Design | 2 | 2024 | 337 | 0.230 |
Why?
|
| Geriatrics | 1 | 2024 | 88 | 0.200 |
Why?
|
| Humans | 11 | 2024 | 34562 | 0.190 |
Why?
|
| Physical Therapy Modalities | 1 | 2023 | 84 | 0.180 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 200 | 0.170 |
Why?
|
| Postural Balance | 1 | 2023 | 152 | 0.170 |
Why?
|
| Adult | 6 | 2022 | 10030 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2022 | 274 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2020 | 11 | 0.160 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 16 | 0.160 |
Why?
|
| Middle Aged | 6 | 2020 | 12726 | 0.150 |
Why?
|
| Bayes Theorem | 1 | 2019 | 85 | 0.140 |
Why?
|
| Food Supply | 1 | 2019 | 68 | 0.140 |
Why?
|
| Aging | 1 | 2024 | 1010 | 0.140 |
Why?
|
| Linear Models | 1 | 2019 | 465 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 614 | 0.130 |
Why?
|
| Prognosis | 2 | 2019 | 1606 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 939 | 0.120 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2015 | 1 | 0.120 |
Why?
|
| Male | 6 | 2020 | 20740 | 0.120 |
Why?
|
| Corneal Diseases | 1 | 2015 | 10 | 0.110 |
Why?
|
| Female | 6 | 2020 | 21532 | 0.110 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 53 | 0.110 |
Why?
|
| Demography | 1 | 2015 | 112 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 21 | 0.110 |
Why?
|
| Decision Trees | 1 | 2014 | 31 | 0.110 |
Why?
|
| Bioprosthesis | 1 | 2015 | 62 | 0.110 |
Why?
|
| Liver Transplantation | 1 | 2015 | 186 | 0.100 |
Why?
|
| Artificial Intelligence | 1 | 2014 | 66 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 137 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3825 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 11022 | 0.100 |
Why?
|
| Mitochondria | 1 | 2014 | 219 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1246 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3623 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2015 | 850 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2020 | 926 | 0.060 |
Why?
|
| Insulin Infusion Systems | 1 | 2022 | 7 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 12 | 0.050 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2022 | 28 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 100 | 0.050 |
Why?
|
| Forecasting | 1 | 2023 | 153 | 0.050 |
Why?
|
| Insulin | 1 | 2022 | 394 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2022 | 529 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 156 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 439 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 596 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 165 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1034 | 0.030 |
Why?
|
| Cause of Death | 1 | 2017 | 245 | 0.030 |
Why?
|
| Prosthesis Fitting | 1 | 2015 | 6 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 510 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 703 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2015 | 76 | 0.030 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2014 | 1 | 0.030 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2014 | 4 | 0.030 |
Why?
|
| Electron Transport | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2014 | 22 | 0.030 |
Why?
|
| Oxidants | 1 | 2014 | 15 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 28 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1607 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 808 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2014 | 60 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 823 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2014 | 111 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2463 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 304 | 0.030 |
Why?
|
| Cell Line | 1 | 2014 | 476 | 0.030 |
Why?
|
| Phenotype | 1 | 2014 | 657 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 1508 | 0.020 |
Why?
|
| United States | 1 | 2019 | 4278 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2367 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 2720 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 4137 | 0.020 |
Why?
|
| Animals | 1 | 2014 | 8579 | 0.010 |
Why?
|